Search Results

Seen & Heard

Editor's Page

IOLs in Glaucoma: Embracing the Spectrum

Arsham Sheybani, MD

MIGS Unplugged Live at ASCRS 2026: Exploring the State of Interventional Glaucoma Today

How drug delivery, procedural synergy, and earlier intervention are reshaping clinical decision-making.

Iqbal Ike K. Ahmed, MD, FRCSC; Sahar Bedrood, MD, PhD; Arsham Sheybani, MD; and I. Paul Singh, MD

Seen & Heard

Different Angles

Are Nonphysiologic IOP Targets Necessary?

Many patients may achieve disease stability without aggressive goals.

Natalia Londoño De Vivero, MD, and Arsham Sheybani, MD

Editor's Page

A Wider Frame of Reference

Arsham Sheybani, MD

The Buzz on Eyetube

Editor's Page

The Right MIGS for the Right Patient

Arsham Sheybani, MD

Seen & Heard

Editor's Page

Missing the Forest for the Sponges

Arsham Sheybani, MD

Seen & Heard

Cover Focus

Diagnosing Uveitis-Glaucoma-Hyphema Syndrome

A diagnostic framework for the modern glaucoma clinician.

Behnam Rabiee, MD; Zachary Mikolaj, MD; and Sayoko Moroi, MD, PhD

IGC Spotlight

Spotlight on the 2025 IGC

Updates from the annual Interventional Glaucoma Consortium.

Editor's Page

Understanding the Subtleties of UGH Syndrome

Arsham Sheybani, MD

Seen & Heard

Editor's Page

Reflections on Change

Arsham Sheybani, MD

Seen & Heard

Editor's Page

The Arsenic Eaters

Arsham Sheybani, MD

Seen & Heard

Rethinking Early Intervention in Glaucoma Care

A live edition of MIGS Unplugged explored innovations in disease management and barriers to widespread adoption of interventional glaucoma.

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Christine Funke, MD; and Brian Shafer, MD